The Practical Application of Genetic Biomarkers in the Individualised Treatment of Breast Cancer
The latest diagnostic and prognostic technology allows clinicians to define appropriate treatment regimens based entirely on the needs and DNA of the individual patient. Choice of breast cancer treatment increasingly depends on your personal mix of gene markers and there is now a new diagnostic test (the EndoPredict) that can provide important information about the way that a tumour is likely to behave at a genetic level.